Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
1805
9.610
 Why?
Anti-Asthmatic Agents
28
2025
264
3.290
 Why?
Adrenal Cortex Hormones
28
2025
487
3.240
 Why?
Forced Expiratory Volume
19
2019
451
1.510
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
928
1.350
 Why?
Severity of Illness Index
20
2020
2974
0.930
 Why?
Administration, Inhalation
25
2025
572
0.930
 Why?
Anti-Inflammatory Agents
10
2016
481
0.840
 Why?
Albuterol
5
2015
76
0.810
 Why?
Bronchodilator Agents
12
2016
187
0.810
 Why?
Lung Transplantation
10
2017
338
0.780
 Why?
Budesonide
14
2016
49
0.770
 Why?
Remote Consultation
4
2025
66
0.720
 Why?
Nedocromil
11
2016
20
0.690
 Why?
Nasal Polyps
1
2021
59
0.670
 Why?
Humans
129
2025
147306
0.670
 Why?
Self Report
3
2023
887
0.660
 Why?
Endpoint Determination
2
2020
85
0.650
 Why?
Pharmacogenetics
2
2015
176
0.640
 Why?
Food Hypersensitivity
1
2022
168
0.620
 Why?
Sinusitis
1
2021
230
0.570
 Why?
Virus Diseases
1
2021
218
0.560
 Why?
Glucocorticoids
4
2022
537
0.550
 Why?
Lung
7
2019
4141
0.550
 Why?
Physicians
2
2021
961
0.540
 Why?
Symptom Assessment
1
2019
137
0.530
 Why?
Hospitalization
13
2020
2496
0.510
 Why?
Sleep Apnea, Obstructive
1
2021
303
0.510
 Why?
Androstadienes
3
2012
77
0.490
 Why?
Bone Density
2
2014
493
0.480
 Why?
Child
53
2022
22980
0.480
 Why?
Disease Progression
14
2020
2892
0.470
 Why?
Managed Care Programs
8
2008
140
0.470
 Why?
Oxygen Inhalation Therapy
4
2020
190
0.470
 Why?
Male
82
2025
73954
0.450
 Why?
Precision Medicine
1
2020
464
0.450
 Why?
Adult
47
2025
41406
0.440
 Why?
Emergency Service, Hospital
9
2013
2416
0.440
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
26
0.430
 Why?
Cost Savings
1
2015
86
0.430
 Why?
Female
81
2025
80081
0.420
 Why?
Practice Patterns, Physicians'
7
2020
1379
0.410
 Why?
Patient Reported Outcome Measures
1
2018
506
0.410
 Why?
Peak Expiratory Flow Rate
2
2011
25
0.390
 Why?
Cost-Benefit Analysis
7
2022
654
0.380
 Why?
Phenotype
6
2025
3216
0.370
 Why?
Middle Aged
40
2025
36821
0.370
 Why?
Comorbidity
4
2021
1672
0.350
 Why?
Academic Medical Centers
3
2024
566
0.330
 Why?
Surveys and Questionnaires
14
2022
6164
0.320
 Why?
Adolescent
37
2019
22826
0.320
 Why?
Medical Records Systems, Computerized
3
2008
96
0.320
 Why?
Administration, Oral
6
2021
874
0.320
 Why?
Mentors
1
2012
218
0.320
 Why?
Respiratory Function Tests
10
2015
545
0.310
 Why?
Quality of Life
12
2023
3246
0.310
 Why?
United States
23
2022
16313
0.300
 Why?
Interprofessional Relations
3
2021
276
0.300
 Why?
Faculty, Medical
1
2012
308
0.290
 Why?
Spirometry
8
2020
235
0.290
 Why?
Child, Preschool
31
2016
12017
0.290
 Why?
Child Development
1
2014
484
0.290
 Why?
Treatment Outcome
16
2025
11947
0.290
 Why?
Group Practice
1
2008
6
0.280
 Why?
Anti-Allergic Agents
2
2008
41
0.270
 Why?
Oxygen
3
2018
998
0.270
 Why?
Computer Simulation
1
2012
1018
0.270
 Why?
Aged
22
2022
26516
0.260
 Why?
Dyspnea
3
2022
252
0.250
 Why?
Drug Utilization
4
2005
171
0.240
 Why?
Randomized Controlled Trials as Topic
8
2020
1777
0.240
 Why?
Primary Health Care
5
2025
1760
0.240
 Why?
Primary Graft Dysfunction
2
2017
33
0.230
 Why?
Quality Assurance, Health Care
1
2008
343
0.230
 Why?
Follow-Up Studies
17
2017
5478
0.230
 Why?
Bronchiolitis Obliterans
3
2017
61
0.230
 Why?
Respiratory Sounds
1
2006
103
0.230
 Why?
Gift Giving
1
2005
9
0.230
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.220
 Why?
Allergists
2
2022
13
0.220
 Why?
Genetic Testing
1
2008
493
0.220
 Why?
Delivery of Health Care
2
2021
951
0.220
 Why?
Specialization
2
2025
137
0.200
 Why?
Medication Adherence
2
2023
540
0.200
 Why?
Cohort Studies
14
2013
6099
0.200
 Why?
Natural Language Processing
1
2025
107
0.200
 Why?
Retrospective Studies
18
2024
17561
0.200
 Why?
Massachusetts
5
2016
181
0.200
 Why?
Time Factors
10
2020
7173
0.200
 Why?
Leadership
2
2022
409
0.200
 Why?
Antibodies, Monoclonal
2
2008
1514
0.200
 Why?
Medicine
1
2025
126
0.190
 Why?
Rhinitis, Allergic, Perennial
1
2003
20
0.190
 Why?
Genetic Variation
1
2008
995
0.190
 Why?
Steroids
8
2011
162
0.190
 Why?
Recurrence
5
2013
1151
0.190
 Why?
Health Status
1
2008
839
0.180
 Why?
Genetic Predisposition to Disease
2
2025
2458
0.180
 Why?
Predictive Value of Tests
9
2012
2133
0.180
 Why?
Beclomethasone
1
2022
8
0.180
 Why?
Models, Theoretical
4
2007
563
0.180
 Why?
Multicenter Studies as Topic
4
2018
417
0.180
 Why?
Young Adult
11
2019
14437
0.170
 Why?
Prevalence
4
2022
2889
0.170
 Why?
Tiotropium Bromide
2
2018
5
0.170
 Why?
Desensitization, Immunologic
1
2022
91
0.170
 Why?
Nebulizers and Vaporizers
2
2020
63
0.170
 Why?
Biomarkers
3
2021
4354
0.170
 Why?
Social Class
2
2022
266
0.160
 Why?
Patient Preference
1
2023
225
0.160
 Why?
Churg-Strauss Syndrome
1
2020
27
0.160
 Why?
Bronchoconstriction
3
2011
29
0.160
 Why?
Pulmonologists
1
2020
14
0.160
 Why?
Granulomatosis with Polyangiitis
1
2020
47
0.160
 Why?
Capacity Building
1
2021
63
0.160
 Why?
Muscarinic Antagonists
1
2020
30
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.150
 Why?
Physician-Patient Relations
2
2021
594
0.150
 Why?
Air Pollution, Indoor
2
2002
171
0.150
 Why?
Electronic Health Records
2
2025
1214
0.150
 Why?
Practice Guidelines as Topic
5
2020
1598
0.150
 Why?
Risk Factors
12
2018
11017
0.150
 Why?
Treatment Adherence and Compliance
1
2019
27
0.140
 Why?
Exercise Test
1
2022
636
0.140
 Why?
Receptors, IgE
2
2009
43
0.140
 Why?
Allergens
1
2021
391
0.130
 Why?
Prognosis
8
2017
4384
0.130
 Why?
Vitamin D
2
2012
405
0.130
 Why?
Fossil Fuels
1
1997
9
0.130
 Why?
Hypersensitivity
1
2020
254
0.130
 Why?
Alemtuzumab
1
2017
15
0.130
 Why?
Photopheresis
1
2017
9
0.130
 Why?
Drug Prescriptions
2
2011
293
0.130
 Why?
Biological Products
1
2020
258
0.120
 Why?
Respiration
1
2017
208
0.120
 Why?
Physicians, Primary Care
3
2021
210
0.120
 Why?
Respiration Disorders
1
1997
78
0.120
 Why?
Emergency Medical Services
2
2007
691
0.120
 Why?
Statistics, Nonparametric
1
2017
430
0.120
 Why?
Drug Therapy, Combination
5
2020
1046
0.120
 Why?
Drug Combinations
3
2012
399
0.120
 Why?
Immunomodulation
1
2017
100
0.120
 Why?
Drug Monitoring
1
2020
402
0.120
 Why?
Tobacco Smoke Pollution
2
2010
227
0.120
 Why?
Socioeconomic Factors
4
2022
1342
0.120
 Why?
Scopolamine Derivatives
1
2015
3
0.120
 Why?
Breath Tests
2
2008
77
0.120
 Why?
Embolism, Fat
1
2015
11
0.110
 Why?
Immunoglobulin G
1
2020
901
0.110
 Why?
Aged, 80 and over
6
2019
8432
0.110
 Why?
Patient Admission
1
2018
220
0.110
 Why?
Cholinergic Antagonists
1
2015
24
0.110
 Why?
Transplants
1
2015
38
0.110
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
103
0.110
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
7
0.110
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.110
 Why?
Genomics
2
2018
839
0.110
 Why?
Longitudinal Studies
6
2017
3029
0.100
 Why?
Graft Rejection
2
2013
523
0.100
 Why?
Respiratory Tract Infections
2
2012
399
0.100
 Why?
Overweight
2
2011
617
0.100
 Why?
Ambulatory Care Information Systems
2
2005
5
0.100
 Why?
Referral and Consultation
1
2021
886
0.100
 Why?
Prednisolone
1
2014
67
0.100
 Why?
Risk
4
2015
927
0.100
 Why?
Telemedicine
1
2023
978
0.100
 Why?
Guideline Adherence
3
2020
590
0.100
 Why?
Postoperative Complications
2
2017
3022
0.100
 Why?
Education, Medical, Continuing
2
2005
134
0.100
 Why?
Airway Obstruction
1
2015
153
0.100
 Why?
Environmental Exposure
3
2006
583
0.100
 Why?
Forecasting
1
2015
391
0.100
 Why?
Bronchial Hyperreactivity
3
2010
104
0.100
 Why?
Transplantation
1
2013
33
0.100
 Why?
Office Visits
4
2011
93
0.090
 Why?
Quality Improvement
1
2022
1321
0.090
 Why?
Insurance Claim Review
1
2013
86
0.090
 Why?
Growth
1
2012
49
0.090
 Why?
Peer Group
2
2012
258
0.090
 Why?
Costs and Cost Analysis
1
2013
221
0.090
 Why?
Methacholine Chloride
3
2008
51
0.090
 Why?
Research
1
2015
435
0.090
 Why?
Double-Blind Method
5
2010
2080
0.090
 Why?
Medicare
2
2022
915
0.090
 Why?
Metered Dose Inhalers
1
2012
8
0.090
 Why?
Cytomegalovirus Infections
2
2012
210
0.090
 Why?
Cost of Illness
3
2003
327
0.090
 Why?
Drug Dosage Calculations
1
2011
27
0.090
 Why?
Feedback
1
2012
181
0.090
 Why?
Logistic Models
5
2017
2142
0.090
 Why?
Mycoses
1
2012
88
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2008
1005
0.090
 Why?
Antifungal Agents
1
2012
153
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
8
0.080
 Why?
Multivariate Analysis
7
2017
1550
0.080
 Why?
Body Height
1
2012
205
0.080
 Why?
Medication Errors
1
2012
85
0.080
 Why?
Professional Role
1
2012
171
0.080
 Why?
Morbidity
2
2022
323
0.080
 Why?
Mycobacterium
1
2012
101
0.080
 Why?
Pneumococcal Vaccines
1
2012
130
0.080
 Why?
Epidemiologic Studies
1
2011
72
0.080
 Why?
Program Development
1
2012
369
0.080
 Why?
Obesity
3
2015
3149
0.080
 Why?
Patient Readmission
1
2016
777
0.080
 Why?
Drug Resistance
1
2011
145
0.080
 Why?
Secondary Prevention
1
2012
253
0.080
 Why?
Diagnostic Errors
1
2012
182
0.080
 Why?
Probability
1
2011
309
0.080
 Why?
Vitamin D Deficiency
1
2012
190
0.080
 Why?
Lung Diseases
1
2017
787
0.080
 Why?
Chi-Square Distribution
2
2017
528
0.080
 Why?
Bronchial Provocation Tests
2
2008
47
0.080
 Why?
Fluticasone
2
2008
53
0.080
 Why?
Pragmatic Clinical Trials as Topic
2
2020
134
0.080
 Why?
Immunoglobulin E
2
2008
316
0.070
 Why?
Vital Capacity
4
2017
293
0.070
 Why?
Incidence
5
2020
2954
0.070
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
30
0.070
 Why?
Lectins, C-Type
1
2009
61
0.070
 Why?
Decision Support Techniques
2
2012
480
0.070
 Why?
Smoking
3
2017
1483
0.070
 Why?
Algorithms
1
2017
1868
0.070
 Why?
Health Services
2
2007
113
0.070
 Why?
Medication Therapy Management
1
2010
73
0.070
 Why?
Ambulatory Care
2
2011
625
0.070
 Why?
Proportional Hazards Models
1
2012
1344
0.070
 Why?
Odds Ratio
4
2017
1084
0.070
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1431
0.070
 Why?
Surgical Wound Infection
1
2012
334
0.070
 Why?
Pandemics
3
2022
1720
0.070
 Why?
Kaplan-Meier Estimate
3
2016
975
0.070
 Why?
Acute Disease
1
2011
1049
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
12
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
20
0.070
 Why?
Eosinophil Cationic Protein
1
2008
9
0.070
 Why?
Cross-Sectional Studies
6
2010
6011
0.070
 Why?
Mixed Function Oxygenases
1
2008
43
0.070
 Why?
Adrenergic beta-Agonists
1
2008
92
0.070
 Why?
Program Evaluation
1
2012
952
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
45
0.070
 Why?
Genetic Techniques
1
2008
66
0.070
 Why?
Quality-Adjusted Life Years
2
2006
126
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
24
0.070
 Why?
State Health Plans
1
2008
28
0.070
 Why?
Markov Chains
2
2006
132
0.070
 Why?
Smoking Cessation
1
2012
441
0.070
 Why?
Cost Sharing
1
2008
23
0.070
 Why?
Trastuzumab
1
2008
119
0.070
 Why?
Reimbursement Mechanisms
1
2008
79
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
50
0.060
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
339
0.060
 Why?
Chronic Disease
3
2017
1845
0.060
 Why?
Omalizumab
1
2007
44
0.060
 Why?
Factor Analysis, Statistical
1
2008
296
0.060
 Why?
Exercise Tolerance
2
2022
289
0.060
 Why?
Health Surveys
2
2006
522
0.060
 Why?
Influenza Vaccines
1
2012
541
0.060
 Why?
Warfarin
1
2008
179
0.060
 Why?
Interviews as Topic
1
2011
932
0.060
 Why?
Antiviral Agents
1
2012
776
0.060
 Why?
Animals, Domestic
1
2006
17
0.060
 Why?
Databases, Factual
1
2012
1504
0.060
 Why?
Tomography, X-Ray Computed
1
2017
2791
0.060
 Why?
Lung Diseases, Interstitial
1
2013
675
0.060
 Why?
Health Services Accessibility
2
2021
1122
0.060
 Why?
Animals
2
2025
38417
0.060
 Why?
Eosinophils
1
2008
319
0.060
 Why?
Physicians, Family
2
2004
179
0.060
 Why?
Health Benefit Plans, Employee
1
2005
25
0.060
 Why?
Biomedical Research
1
2012
723
0.050
 Why?
Models, Biological
1
2012
1772
0.050
 Why?
Database Management Systems
1
2005
51
0.050
 Why?
Hip Fractures
1
2006
88
0.050
 Why?
Health Policy
1
2008
405
0.050
 Why?
Patients
1
2006
184
0.050
 Why?
Insurance Coverage
1
2006
248
0.050
 Why?
Utilization Review
1
2004
39
0.050
 Why?
Infant
3
2008
10195
0.050
 Why?
Patient Education as Topic
3
2005
781
0.050
 Why?
Body Mass Index
3
2015
2470
0.050
 Why?
Gene Expression Profiling
1
2011
1794
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
663
0.050
 Why?
Clinical Competence
1
2012
1260
0.050
 Why?
Medicaid
1
2008
475
0.050
 Why?
Nitric Oxide
1
2008
892
0.050
 Why?
Attitude to Health
1
2006
431
0.050
 Why?
Vaccination
1
2012
1443
0.050
 Why?
Mass Screening
1
2012
1375
0.050
 Why?
Sex Factors
3
2016
2136
0.050
 Why?
Anticoagulants
1
2008
751
0.050
 Why?
Case Management
1
2003
68
0.050
 Why?
Choice Behavior
1
2004
181
0.050
 Why?
Puerto Rico
1
2022
64
0.050
 Why?
Clinical Trials as Topic
2
2005
1072
0.040
 Why?
Parents
3
2006
1428
0.040
 Why?
Symptom Flare Up
1
2022
37
0.040
 Why?
Anti-Bacterial Agents
2
2004
1940
0.040
 Why?
Sputum
1
2004
302
0.040
 Why?
Circadian Rhythm
1
2006
514
0.040
 Why?
Academies and Institutes
1
2022
61
0.040
 Why?
Health Services Research
1
2004
392
0.040
 Why?
Lung Neoplasms
1
2015
2679
0.040
 Why?
Minority Groups
1
2003
286
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
75
0.040
 Why?
Electronics
1
2021
65
0.040
 Why?
Survival Rate
2
2016
2110
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
116
0.040
 Why?
Efficiency
1
2021
103
0.040
 Why?
Sample Size
1
2020
124
0.040
 Why?
Health Care Reform
1
2021
109
0.040
 Why?
Schools, Medical
1
2021
159
0.040
 Why?
Patient Compliance
2
2016
591
0.040
 Why?
Risk Assessment
3
2020
3784
0.040
 Why?
Patient Selection
2
2020
746
0.040
 Why?
Language
1
2022
326
0.040
 Why?
Stress, Psychological
1
2007
1174
0.040
 Why?
Cluster Analysis
2
2014
502
0.040
 Why?
Time
1
2019
84
0.040
 Why?
Health Education
1
2002
346
0.040
 Why?
Quality of Health Care
1
2003
697
0.030
 Why?
Poland
1
2017
34
0.030
 Why?
Bronchitis, Chronic
1
2017
16
0.030
 Why?
Republic of Korea
1
2017
43
0.030
 Why?
Cooperative Behavior
1
2021
471
0.030
 Why?
Patient-Centered Care
1
2003
552
0.030
 Why?
Sensitivity and Specificity
3
2013
2017
0.030
 Why?
Nitrogen Dioxide
1
1997
45
0.030
 Why?
Geography
1
2018
187
0.030
 Why?
Aftercare
1
2019
225
0.030
 Why?
Monitoring, Physiologic
2
2012
290
0.030
 Why?
Self Concept
1
2019
259
0.030
 Why?
Netherlands
1
2016
85
0.030
 Why?
Long-Term Care
1
2018
118
0.030
 Why?
Antineoplastic Agents
1
2008
2231
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
127
0.030
 Why?
Pediatrics
1
2005
1139
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
10
0.030
 Why?
Formoterol Fumarate
1
2015
6
0.030
 Why?
Perception
1
2019
378
0.030
 Why?
Salmeterol Xinafoate
1
2015
20
0.030
 Why?
Ethanolamines
1
2015
14
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
36
0.030
 Why?
Treatment Failure
1
2016
360
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2030
0.030
 Why?
Education
1
2015
106
0.030
 Why?
Postoperative Period
1
2016
351
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2223
0.030
 Why?
Feasibility Studies
1
2020
1147
0.030
 Why?
Self Efficacy
1
2019
423
0.030
 Why?
Immunosuppressive Agents
2
2015
840
0.030
 Why?
Fatal Outcome
1
2015
306
0.030
 Why?
Age Factors
3
2008
3372
0.030
 Why?
Biopsy
2
2013
1093
0.030
 Why?
Pilot Projects
1
2020
1912
0.030
 Why?
Combined Modality Therapy
1
2017
1281
0.030
 Why?
Patient Acceptance of Health Care
1
2021
895
0.020
 Why?
Gene Expression
1
2018
1481
0.020
 Why?
Telephone
2
2005
177
0.020
 Why?
Echinocandins
1
2012
8
0.020
 Why?
Lipopeptides
1
2012
17
0.020
 Why?
Aspergillosis
1
2012
24
0.020
 Why?
Amphotericin B
1
2012
36
0.020
 Why?
Intention to Treat Analysis
1
2012
79
0.020
 Why?
Candidiasis
1
2012
64
0.020
 Why?
Tissue Donors
1
2015
427
0.020
 Why?
Transplantation, Homologous
1
2013
422
0.020
 Why?
Mycobacterium avium Complex
1
2012
87
0.020
 Why?
Age Distribution
2
2003
406
0.020
 Why?
Cromolyn Sodium
2
2001
6
0.020
 Why?
Hypoxia
1
2019
1209
0.020
 Why?
Leukotriene Antagonists
1
2011
24
0.020
 Why?
Triazoles
1
2012
191
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
394
0.020
 Why?
Self Care
2
2005
395
0.020
 Why?
Functional Residual Capacity
1
2010
7
0.020
 Why?
Reference Values
1
2012
800
0.020
 Why?
Costa Rica
1
2010
18
0.020
 Why?
Colorado
1
2021
4591
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
189
0.020
 Why?
Principal Component Analysis
1
2011
196
0.020
 Why?
Health
1
2010
82
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Genome-Wide Association Study
1
2016
1496
0.020
 Why?
Environment
1
2011
297
0.020
 Why?
Observation
1
2008
54
0.020
 Why?
Sex Ratio
1
2008
17
0.020
 Why?
Least-Squares Analysis
1
2008
73
0.020
 Why?
Models, Econometric
1
2008
35
0.020
 Why?
Prospective Studies
2
2012
8166
0.020
 Why?
Health Services Administration
1
2007
9
0.020
 Why?
Treatment Refusal
1
2008
99
0.020
 Why?
Intelligence
1
2007
117
0.020
 Why?
Social Isolation
1
2007
74
0.020
 Why?
Puberty
1
2008
137
0.020
 Why?
Body Weight
1
2011
976
0.020
 Why?
Child Behavior Disorders
1
2007
119
0.010
 Why?
Exercise
1
2016
2219
0.010
 Why?
Genotype
1
2009
1875
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1162
0.010
 Why?
Insurance, Health
1
2007
321
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Organizational Innovation
1
2004
119
0.010
 Why?
Health Status Indicators
1
2004
168
0.010
 Why?
Case-Control Studies
1
2010
3660
0.010
 Why?
Systems Integration
1
2003
36
0.010
 Why?
Computer Systems
1
2003
55
0.010
 Why?
Motor Activity
1
2007
719
0.010
 Why?
Histamine H1 Antagonists
1
2002
24
0.010
 Why?
Self Disclosure
1
2002
61
0.010
 Why?
Drug Administration Schedule
1
2004
789
0.010
 Why?
Child Welfare
1
2004
233
0.010
 Why?
Administration, Intranasal
1
2002
94
0.010
 Why?
Confidence Intervals
1
2002
330
0.010
 Why?
Regression Analysis
1
2003
1003
0.010
 Why?
Nurse's Role
1
2003
149
0.010
 Why?
Point-of-Care Systems
1
2003
189
0.010
 Why?
Health Care Surveys
1
2002
538
0.010
 Why?
Sex Distribution
1
2001
390
0.010
 Why?
Patient Satisfaction
1
2004
718
0.010
 Why?
Linear Models
1
2002
852
0.010
 Why?
Disease Management
1
2003
654
0.010
 Why?
Bronchoscopy
1
2000
228
0.010
 Why?
Decision Support Systems, Clinical
1
2003
278
0.010
 Why?
Caregivers
1
2007
1091
0.010
 Why?
Internet
1
2003
696
0.010
 Why?
Pregnancy
1
2010
7276
0.010
 Why?
Survival Analysis
1
2000
1386
0.010
 Why?
Infant, Newborn
1
2004
6543
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)